persister cell formation
traitmech:000082 · CLASS · REVIEWED
Formation of dormant phenotypic variants (persister cells) that are transiently tolerant to antibiotics and other lethal stresses without carrying genetic resistance, arising stochastically in a population.
Persister dormancy and antibiotic tolerance
Edge evidence
-
dormancy process
confers
persister cell formation
METPO:2007700Dormancy underlies stochastic persister formation.
-
DOI:10.1146/annurev.micro.112408.134306
-
-
persister cell formation
enables
antibiotic tolerance
RO:0002327Persister cells transiently tolerate antibiotics.
-
DOI:10.1038/nrmicro1557
-
-
persister cell formation
characterized by
biphasic killing curve
Persistence produces a biphasic time-kill curve diagnostic of a tolerant subpopulation.
-
DOI:10.1128/ecosalplus.esp-0025-2022
-
-
persister cell formation
has characteristic
minimum inhibitory concentration of susceptible cells
Persisters retain the same MIC as susceptible cells, distinguishing persistence from resistance.
-
DOI:10.1186/s12866-024-03628-3
-
-
antibiotic resistance
has characteristic
elevated minimum inhibitory concentration
Resistant bacteria have a significantly higher MIC, contrasting with the unchanged MIC of persisters.
-
DOI:10.1186/s12866-024-03628-3
-
-
antibiotic tolerance
has characteristic
whole-population phenotype
Tolerance applies to the whole population, whereas persisters are a small subpopulation.
-
DOI:10.1186/s12866-024-03628-3
-
-
persister cell formation
enables
oxidative phosphorylation
RO:0002327Persisters actively undergo a residual level of oxidative phosphorylation even during nutrient starvation.
-
DOI:10.1111/1751-7915.70042
-
-
oxidative phosphorylation
results in
proton motive force
Residual oxidative phosphorylation generates proton motive force that sustains persister survival.
-
DOI:10.1111/1751-7915.70042
-
Provenance
- Source
- METPO (2025-11-25)
- Definition source
- DOI:10.1146/annurev.micro.112408.134306
Parent traits (1)
Synonyms (1)
- persistence
kg-microbe context
Matched 1 kg-microbe node via parent_proxy.
METPO:1000059[-2.682, -2.070, -3.656, -0.652, …]
Nearest neighbors in embedding space
- environment cadmium tolerant 1.000
- morphology sulfur globule 1.000
- environment cobalt tolerant 1.000
- environment copper tolerant 1.000
- environment desiccation tolerant 1.000
- environment piezophilic 1.000
- environment obligately piezophilic 1.000
- morphology gas vesicle 1.000
Deep research
# Curation report: persister cell formation ## Trait record and recommended scope - **Trait label:** persister cell formation - **Trait identifier:** `traitmech:000082` - **Category / kind / status:** PHYSIOLOGY / CLASS / REVIEWED - **Parent:** `traitmech:000080` - **Recommended operational definition:** formation or enrichment of a reversible, non-heritable physiological subpopulation that survives an otherwise lethal antimicrobial or stress exposure, retains approximately the parental MIC, and can resume growth and regenerate a predominantly susceptible population after stress removal. The strongest operational evidence combines: **(i)** survival at a lethal exposure, **(ii)** biphasic or otherwise heterogeneous time-kill kinetics, **(iii)** unchanged susceptibility after recovery, and **(iv)** demonstrable regrowth. Persistence is usually a population-level observation about a rare subpopulation, not a constitutive property of every cell. No unique molecular marker currently identifies all persisters, so a single gene-expression signature, low ATP measurement, or colony count should not alone establish the trait. (yuan2024molecularmechanismand pages 2-3, yuan2024molecularmechanismand pages 7-9, pont2024proteomiccharacterizationof pages 1-2) ### Boundary cases | Nearby phenomenon | Distinction from `traitmech:000082` | |---|---| | Genetic antibiotic resistance | Resistant cells have a heritable increase in MIC or ability to grow under treatment. Persisters usually retain parental susceptibility after recovery. Persistence mutations such as `hipA7` can alter the *frequency* of entering the phenotype without making an individual persister genetically resistant. (niu2024bacterialpersistersmolecular pages 3-4, blattman2024identificationandgenetic pages 1-2) | | Population-wide tolerance | Tolerance prolongs killing time for most or all of the population without necessarily increasing MIC; persistence denotes a minority with a markedly different killing rate. In practice these can form a continuum, so survival-distribution evidence is preferable to terminology alone. (niu2024bacterialpersistersmolecular pages 3-4, prasetyoputri2019theeagleeffect pages 8-9) | | Heteroresistance | Heteroresistance comprises subpopulations with different, often unstable but growth-permitting MICs. It should not be curated as persistence unless recovered survivors retain parental MIC and satisfy reversible survival/regrowth criteria. | | VBNC state | VBNC cells remain viable but do not form colonies on routine medium after removal of the immediate stress; persisters are operationally culturable after recovery. Both can have low ATP and may overlap biologically, making single-cell recovery assays important. (li2024intracellularatpconcentration pages 1-2) | | Small-colony variants | SCVs can be transient or genetically stable and often have respiratory defects and characteristic small colonies. They may overlap with persisters but are not synonymous; stable SCVs with altered susceptibility belong in a separate phenotype. (goormaghtigh2024understandingstaphylococcusaureus pages 8-9) | | Dormancy | Dormancy, slow growth, and low metabolism are frequent mechanisms or correlates, not mandatory definitions. Recent single-cell evidence shows distinct persister states and warns against equating every non-growing cell with a persister. (blattman2024identificationandgenetic pages 1-2, blattman2024identificationandgenetic pages 3-4) | | Biofilm tolerance | Matrix restriction, nutrient gradients, altered targets, and community physiology can protect the whole biofilm. Curate biofilm → persister enrichment only when the persister subpopulation itself is measured; do not collapse all biofilm recalcitrance into this trait. (yuan2024molecularmechanismand pages 7-9, vergoz2025antibioticpersistercells pages 3-3) | ## Current mechanistic interpretation Persister formation is best represented as a **many-to-one causal graph**, not a universal linear pathway. Starvation, growth transition, antibiotic damage, host stress, signaling, and stochastic metabolic fluctuations can initiate different routes. These routes often converge on reduced translation, altered central metabolism and ATP availability, prolonged lag or dormancy, reduced antibiotic-target activity, and reversible survival. The relative importance of each route depends on species, strain, growth phase, antibiotic, concentration, and exposure duration. (niu2024bacterialpersistersmolecular pages 3-4, blattman2024identificationandgenetic pages 3-4) A major 2024 advance was the single-cell RNA atlas and genome-scale CRISPRi study of *Escherichia coli*. Persisters generated by several genetic and physiological models converged on a state distinct from standard stationary or lag phases and dominated by **translational deficiency**. In wild-type cultures, 6-day starvation increased antibiotic persistence to nearly 1%; 7.4% of those cells occupied the inferred persister transcriptomic cluster. (blattman2024identificationandgenetic pages 1-2, blattman2024identificationandgenetic pages 3-4) That study also identified model-dependent causal drivers. Loss of `lon` strongly reversed `metG*` hyper-persistence; `lon` deletion reduced wild-type survival 5.2-fold, while combined `lon`/`sulA` deletion in the `metG*` background reduced lag-phase antibiotic survival by more than 100,000-fold. `yqgE` promoted post-starvation dormancy, and its expression was sufficient to increase lag and persistence in wild type. These are unusually strong candidates because they are supported by perturbation rather than expression correlation alone. (blattman2024identificationandgenetic pages 5-6, blattman2024identificationandgenetic pages 7-8, blattman2024identificationandgenetic pages 6-6) A second 2024 primary study found a species-specific regulatory intervention in *Enterococcus faecalis* OG1RF. Under 8 h of 20 mg/mL levofloxacin, the untreated persistence rate was 0.109%; 10–12 ng/mL cCF10 lowered it to approximately 0.047–0.050%. The proposed chain is cCF10 uptake through Opp/Opp2, reduced (p)ppGpp accumulation, maintenance of ATP-generating and DNA-replication activity, and increased levofloxacin susceptibility. Natural extracellular cCF10 concentrations reported in the study were only 0.04–0.08 ng/mL, so this is an experimental intervention rather than an established natural regulator at the tested dose. (zhu2024pheromoneccf10inhibits pages 7-11, zhu2024pheromoneccf10inhibits pages 11-12, zhu2024pheromoneccf10inhibits pages 1-2) Low ATP remains an important but context-sensitive node. Single-cell QUEEN-7μ measurements showed lower ATP in both *E. coli* persisters and VBNC cells than in sensitive or culturable cells, with overlap between sensitive cells and persisters. The study established a 12.5 µM threshold for separating VBNC from culturable cells, not a universal persister threshold; consequently, “low ATP causes persister formation” is weaker than “low ATP is associated with dormant cell fate.” (li2024intracellularatpconcentration pages 1-2) | priority | candidate causal chain or edge | organism/context | evidence class | confidence | main caution | |---|---|---|---|---|---| | High | starvation / post-stationary transition -> translational deficiency state -> persister formation | *Escherichia coli*; lag-dependent persistence after starvation/growth transition; ampicillin/ciprofloxacin assays (blattman2024identificationandgenetic pages 1-2, blattman2024identificationandgenetic pages 3-4) | 2024 primary single-cell transcriptomics + survival assays | High | Convergent state is strong, but exact upstream trigger may vary by strain/model | | High | **lon** promotes persister formation / long lag; **lon** loss strongly reduces hyper-persistence | *E. coli* metG* model; CRISPRi and deletion; lag-time and antibiotic-survival readouts (blattman2024identificationandgenetic pages 5-6, blattman2024identificationandgenetic pages 7-8, blattman2024identificationandgenetic pages 6-6) | 2024 primary genetic perturbation | High | Strongest in metG* starvation-linked model; taxon/model scope should be retained | | High | **yqgE** promotes post-starvation dormancy and persistence; **yqgE** expression is sufficient to increase lag and persistence | *E. coli*; metG* and wild-type contexts (blattman2024identificationandgenetic pages 7-8, blattman2024identificationandgenetic pages 1-2) | 2024 primary genetic perturbation | High | Mechanism downstream of YqgE remains incompletely resolved | | High | cCF10 -> Opp/Opp2 uptake system -> reduced (p)ppGpp accumulation / maintained metabolism -> reduced persister formation | *Enterococcus faecalis* OG1RF; levofloxacin 20 mg/mL for 8 h; cCF10 10-12 ng/mL lowers persistence from 0.109% to ~0.047-0.050% (zhu2024pheromoneccf10inhibits pages 5-7, zhu2024pheromoneccf10inhibits pages 7-11, zhu2024pheromoneccf10inhibits pages 11-12, zhu2024pheromoneccf10inhibits pages 1-2) | 2024 primary intervention study | High | Single strain; pheromone concentrations above natural extracellular levels; not yet generalized | | High | ciprofloxacin (10x MIC) exposure -> persister formation with biphasic killing and unchanged susceptibility | *Enterococcus faecium* AUS004; MIC 2 ug/mL; >2-log initial kill then plateau (pont2024proteomiccharacterizationof pages 1-2) | 2024 primary induction/phenotyping study | High | Establishes phenotype robustly, but downstream protein changes are mostly associative | | Medium | HipA activation / hipA7 -> GltX inhibition -> uncharged tRNA -> RelA activation -> (p)ppGpp accumulation -> persister formation | Mainly *E. coli*; foundational model summarized in 2024 reviews (yuan2024molecularmechanismand pages 6-7, yuan2024molecularmechanismand pages 3-6) | Review-supported established mechanism | Medium-High | Widely cited but not uniformly dominant across taxa/conditions | | Medium | TisB toxin activity -> PMF collapse / ATP synthesis inhibition -> dormancy -> increased persistence | Mainly *E. coli* under SOS/antibiotic stress (yuan2024molecularmechanismand pages 6-7, yuan2024molecularmechanismand pages 3-6) | Review-supported established mechanism | Medium | Strong within specific TA-module contexts; not a universal persister pathway | | Medium | low intracellular ATP state -> persister/VBNC fate association | *E. coli* single-cell ATP biosensor study (li2024intracellularatpconcentration pages 1-2) | 2024 primary single-cell physiology | Medium | Clear association; direct causality for persister formation is weaker than for VBNC resuscitation | | Medium | TCA-cycle / central metabolism activity modulates persister lag and survival | *E. coli* CRISPRi pathway-level effects across models (blattman2024identificationandgenetic pages 5-6, blattman2024identificationandgenetic pages 23-30) | 2024 primary genetic screen | Medium | More pathway-level than node-specific; direction may depend on perturbation and model | | Low | oxidative-stress and stress-proteostasis proteins (e.g., CspA, PrsA, ClpX) associate with persister state | *E. faecium* ciprofloxacin persisters (pont2024proteomiccharacterizationof pages 1-2) | 2024 primary proteomics, association only | Low | Differential abundance does not establish causal role | | Low | biofilm formation enriches/promotes persister formation | Cross-species; especially *E. faecalis* and review contexts (zhu2024pheromoneccf10inhibits pages 7-11, vergoz2025antibioticpersistercells pages 3-3, niu2024bacterialpersistersmolecular pages 6-7) | Mixed primary + review contextual evidence | Low-Medium | Community-level tolerance may be confounded with true single-cell persistence; avoid over-curation as direct edge | | Low | SOS / DNA repair genes promote persistence | Review-supported across taxa; some strain-specific support (yuan2024molecularmechanismand pages 6-7, vergoz2025antibioticpersistercells pages 8-8, niu2024bacterialpersistersmolecular pages 28-29) | Review-supported / indirect primary support | Low-Medium | Often difficult to separate cause of persister entry from damage response after antibiotic exposure | *Table: This table ranks candidate causal edges for persister cell formation by curation priority, emphasizing direct 2024 perturbation evidence first and separating established review-backed mechanisms from association-only observations. It is useful for deciding which nodes and edges are safest to curate now versus which should remain provisional.* ## Candidate graph nodes Identifiers below are limited to stable CURIEs that can be assigned confidently; unresolved entities remain label-only rather than receiving invented identifiers. ### Trait and organism nodes
Curation history
-
·
PROPOSED_FROM_RESEARCH · claude
Proposed candidate PHYSIOLOGY trait (persister cell formation); sub-variant of dormancy. Distinct from genetic antibiotic resistance.
-
·
CURATED_CAUSAL_GRAPH · claude
Added evidence-backed causal graph (persister dormancy/tolerance) with GO node grounding and RO predicate groundings; promoted PROPOSED to REVIEWED.
-
·
ENRICH_CAUSAL_GRAPH · claude
Added 6 evidence-backed generic edges (7 new nodes) from the deep-research report.
-
·
GROUND_CAUSAL_PREDICATES · claude
Grounded 1 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (RO:0002327×1).
-
·
GROUND_CAUSAL_NODES · claude
Grounded 1 causal-node grounding field(s) via mappings/node_grounding.tsv (GO:0006119×1).
-
·
MIGRATE_ENABLES_TRAIT_EDGES · claude
Migrated 1 causal edge(s) off enables/RO:0002327 with a TRAIT object (1 to confers), issue 302. RO:0002327 has range 'biological process or activity', which a trait (a disposition) cannot satisfy, so the previous form entailed trait is-a BiologicalProcessOrActivity. The replacements are proposed in proposals/metpo_traitmech_v8 and are placeholder ids until METPO mints them.
-
·
NORMALISE_NODE_TYPE · claude
Normalised causal-node type(s) so one node_id means one thing corpus-wide (issue 356): proton_motive_force: BIOLOGICAL_PROCESS -> STATE. The schema's OWN example of STATE: 'a bioenergetic or molecular state of the cell (e.g. proton motive force ...) ... the state is the gradient / steady-value, not its establishment'. All 35 occurrences describe the gradient -- every description across all four types reads 'electrochemical proton gradient', including the 13 typed BIOLOGICAL_PROCESS ('Transmembrane electrochemical gradient generated by respiration'), which name the gradient and its provenance rather than the generating process. Nothing here means the establishment, so this is a retype and not a rename; records that DO mean the process already use a separate id (proton_motive_force_generation in ph_delta.yaml). Also settles the one edge #356 was filed for: phototrophic.yaml's CAPACITY typing was blocking `powers` (METPO:2007900), which is gated to BIOLOGICAL_PROCESS|STATE.
-
·
NORMALISE_NODE_TYPE · claude
Under the PATHWAY-vs-BIOLOGICAL_PROCESS rule, one node_id means one thing corpus-wide (issue 356): oxidative_phosphorylation is typed PATHWAY. PATHWAY is a named, conventionally enumerable multi-step route; BIOLOGICAL_PROCESS is everything else. A named route through enumerable complexes -- environment/ph_delta_mid1.yaml lists them (nuo, cyo, ndh, sdh). The rule breaks what was a 2-2 tie before this tranche.